Trials / Recruiting
RecruitingNCT05355415
Adaptive Optics Imaging of Outer Retinal Diseases
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 100 (estimated)
- Sponsor
- Food and Drug Administration (FDA) · Federal
- Sex
- All
- Age
- 21 Years
- Healthy volunteers
- —
Summary
The objective of the study is to collect adaptive optics (AO) retinal images from human subjects with outer retinal diseases (diseases of the outer retina including photoreceptor, retinal pigment epithelium (RPE), basement membrane or choroidal pathologies) to develop new diagnostic methods, biomarkers, and clinical endpoints.
Detailed description
Objective: The objective of the study is to collect adaptive optics (AO) retinal images from human subjects with outer retinal diseases (diseases of the outer retina including photoreceptor, retinal pigment epithelium (RPE), basement membrane or choroidal pathologies) to develop new diagnostic methods, biomarkers, and clinical endpoints. Study Population: Up to fifty (50) healthy volunteers without eye disease (Cohort 1) and up to fifty (50) affected participants with any type of outer retinal disease (Cohort 2) will be enrolled. Design: This is a longitudinal study protocol where participants will be imaged with investigational multimodal AO (mAO) retinal imaging systems that include optical coherence tomography (OCT) and scanning laser ophthalmoscopy (SLO) channels over three years. High resolution OCT and SLO videos will be collected while the instruments automatically detect and correct for image distortion caused by ocular aberrations. In general, videos of different retinal cellular structures will be acquired from several retinal locations using various imaging modes. Outcome Measures: The primary outcomes for this protocol are development of new diagnostic methods and disease biomarkers, investigation of cellular morphological and functional changes due to various outer retinal diseases, and development of new AO clinical endpoints for novel therapies.
Conditions
- Retinal Degeneration
- Age-Related Macular Degeneration
- Retinitis Pigmentosa
- Hydroxychloroquine Retinopathy
- Usher Syndromes
- Late-Onset Retinal Degeneration
- Cone Dystrophy
- Cone Rod Dystrophy
- Rod Cone Dystrophy
- Rod Dystrophy
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Adaptive optics imaging | Adaptive optics scanning laser ophthalmoscopy (AOSLO) and adaptive optics - optical coherence tomography (AO-OCT) retinal imaging |
Timeline
- Start date
- 2021-08-27
- Primary completion
- 2026-08-27
- Completion
- 2026-08-27
- First posted
- 2022-05-02
- Last updated
- 2025-04-03
Locations
2 sites across 1 country: United States
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT05355415. Inclusion in this directory is not an endorsement.